Eiger BioPharmaceuticals has announced disappointing results from a study of Peginterferon Lambda-1a (Lambda) in outpatients with mild and uncomplicated COVID-19.
Wednesday's top analyst upgrades, downgrades and initiations included Amazon.com, Boeing, Broadcom, Cisco Systems, IBM, Netflix, Rio Tinto, Tesla, Verizon, Visa and Xerox.
The top analyst upgrades, downgrades and initiations on Wednesday included AbbVie, Archer Daniels Midland, ConocoPhillips, FedEx, Fox, Kinder Morgan, Lennar, Micron Technology, Slack Technologies and...
24/7 Wall St. has picked a few of those standouts from Tuesday to highlight. We have included information about each company, as well as recent trading activity and the consensus price target.
The top analyst upgrades, downgrades and initiations seen on Tuesday included Activision Blizzard, AK Steel, Applied Materials, Cree, Dell Technologies, Etsy, Lam Research, Nvidia, Square, 3D...
24/7 Wall St. has identified 10 highly speculative stocks that have been received Wall Street analyst calls in the past 10 days in which the analysts have projected upside of 50% to 300%.
24/7 Wall St. has identified several biotech analyst calls from Wall Street wherein the analysts are projecting upside of 100% to about 400%.
The top analyst upgrades, downgrades and other research calls from Thursday include AIG, Baxter, Cisco, Eiger BioPharmaceuticals, Energy Transfer Equity, Juniper Networks, National Oilwell Varco,...
Here is a 24/7 Wall St. calendar with a few of the biggest biotech and pharmaceutical companies expecting clinical trial and FDA updates in April.
This year is shaping up to be a stellar one for biotech. Investors are looking for growth and upside, and that can drive the interest in biotechs ever higher.
Investors have to be careful and disciplined to know what they are investing in. That is true enough for the large companies and exchange traded funds, but it's exponentially true for the highly...
Eiger BioPharmaceuticals watched its shares crater on Tuesday after the firm announced that its midstage study in pulmonary arterial hypertension did not meet its primary endpoint.
The top analyst upgrades, downgrades and other research calls from Friday include Cheniere, Cisco, Eli Lilly, Intel, Kroger, Nokia, Rite Aid, Roku, Teva Pharmaceuticals, Tyson Foods, Walgreens Boots...
Jefferies has compiled a list of over 30 biotech events taking place in 2018 that could result in significant stock moves. Some stocks have the potential to double or even crater, should a study be...
The top analyst upgrades, downgrades and other research calls from Tuesday include Altria, Apple, General Motors, Procter & Gamble and Walmart.